Compare Guardant Health Inc. Common Stock (GH) vs Micron Technology, Inc. (MU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs Micron Technology, Inc. — how do they compare? Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.58B), while Micron Technology, Inc. trades at $1,058.5 (market cap $1.23T). The key difference: Micron Technology, Inc. is far larger — about 54.5× Guardant Health Inc. Common Stock's market cap, and Micron Technology, Inc. pays a 0.06% dividend while Guardant Health Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and Micron Technology, Inc. for 48 Days on average.
| GH | MU | |
|---|---|---|
Market Cap | $22.58B | $1.23T |
Volume | 2,200,599 | 30,214,899 |
Sector | Health | Technology |
52-Week High | $187.22 | $1.21K |
52-Week Low | $61.73 | $181.60 |
Typical Hold Time | 0 Days | 48 Days |
Enterprise Value | $23.22B | $1.19T |
Dividend Yield | — | 0.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Micron Technology (MU) trades at $1,035.84, down 0.93% today but remains in a strong uptrend with a 500% gain over the past year. The stock exhibits bullish technical signals, supported by robust fundamentals including a 379% YoY revenue surge in fiscal 2026 and consistent earnings beats. Analyst sentiment is overwhelmingly positive, with 83% recommending Buy, citing AI-driven memory demand and strategic customer agreements securing future revenue.
Outlook: Micron is positioned for sustained growth through 2030 due to AI memory demand and supply constraints, but risks include cyclical slowdowns and valuation sensitivity. The consensus price target of $1,590 implies 53% upside, though high volatility and competitive pressures warrant caution for new investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About Micron Technology, Inc.
Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →
